|
Center for International Blood and Marrow Transplant Research (CIBMTR) Advisory Committee
|
Committee, Work group, Advisory group, or Task Force
|
HRSA
|
NCI, CC, NHLBI, NIAID
|
Staff from NCI, NHLBI and NIAID serve on the Advisory Committee for the Center for International Blood and Marrow Transplant Research (CIBMTR), to provide oversight of the international bone marrow transplant registry.
|
|
Center for Substance Abuse Treatment (CSAT) Hispanic Stakeholders Committee
|
Committee, Work group, Advisory group, or Task Force
|
SAMHSA
|
NIDA
|
Committee set up by Center for Substance Abuse Treatment (CSAT) to advise CSAT director on issues pertaining to Hispanic drug abuse treatment needs.
|
|
Centers for Medicare & Medicaid Services (CMS) Demonstration Project
|
Research Initiative
|
CMS
|
NICHD, NINDS
|
Initiative to design Centers for Medicare & Medicaid Services (CMS) demonstration projects to explore new healthcare delivery options and payment strategies as directed by the Patient Protection and Affordable Care Act. This work is currently under development.
|
|
Chemical Hazards Emergency Medical Management (CHEMM)
|
Resource Development
|
ATSDR, CDC, OS
|
NLM
|
This activity is to develop a comprehensive web resource: Chemical Hazards Emergency Medical Management (CHEMM) is a tool designed to provide access to comprehensive sets of information about chemical hazards via a user-friendly interface.
|
|
Child Abuse and Neglect Working Group (CANWG)
|
Committee, Work group, Advisory group, or Task Force
|
ACF, HRSA, SAMHSA
|
NICHD, CSR, NIAAA, NIDA, NIMH, NINDS
|
The NIH Child Abuse and Neglect Working Group (CANWG) was established in response to a recent directive by the House Committee on Appropriations, which requested that NIH report on current NIH efforts, accomplishments, and future plans for research on child abuse and neglect. The CANWG is co-chaired by program staff from NICHD and NIDA (formally NIMH). The working group is also a subcommittee of the Federal Interagency Workgroup on Child Abuse and Neglect.
|
|
Childhood Cancer Among Children with Birth Defects in California
|
Research Initiative
|
CDC
|
NCI
|
In collaboration with investigators from the Birth Defects Branch, CDC, Stanford University and the Northern California Cancer Center, a registry study has been undertaken that links data from the California Birth Defects Registry and the California State Cancer Registry to quantify risks of total and specific types of pediatric cancer associated with structural birth defects according to phenotype.
|
|
Children''s Environmental Health Task Force Chemical Exposures Workgroup
|
Committee, Work group, Advisory group, or Task Force
|
ATSDR, CDC, FDA, OS
|
NIEHS, NIAID, NICHD
|
An interagency collaboration to examine potentially unrecognized health threats to children from environmental exposures
|
|
Children''s Mental Health
|
Research Initiative
|
CDC
|
NIMH
|
The purpose of this agreement is to provide funds for continued support by the CDC for data collection, analysis, and dissemination of results from a study on children identified with mental disorders/conditions in the National Survey of Children with Special Health Care Needs. Y1-MH-0301
|
|
Chronic Fatigue Syndrome Advisory Committee (CFSAC)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, FDA, HRSA, OS
|
OD, NCCAM, NCI, NCATS, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR
|
The Chronic Fatigue Syndrome Advisory Committee (CFSAC) provides advice and recommendations to the Secretary of Health and Human Services via the Assistant Secretary for Health of the U.S. Department of Health and Human Services on issues related to chronic fatigue syndrome (CFS). These include: 1) factors affecting access and care for persons with CFS; 2) the science and definition of CFS; and 3) broader public health, clinical, research and educational issues related to CFS.
|
|
Chronic Toxicity Test for Bisphenol A
|
Research Initiative
|
FDA
|
NIEHS
|
The FDA will assess BPA toxicity using a two year exposure starting during gestation in SD rats; this will be a GLP ("good laboratory practice") guideline study. The NIEHS has funded twelve researchers who will add specific disease associated endpoints to the standard guideline study.
|